ʻaoʻao_banner

huahana

ʻO ka ʻaila ʻaila Macrocephalae Rhizoma kūlohelohe OEM

wehewehe pōkole:

Ma ke ʻano he lāʻau chemotherapeutic maikaʻi, hoʻohana nui ʻia ka 5-fluorouracil (5-FU) no ka mālama ʻana i nā maʻi maʻi maʻi ma ka ʻōpū o ka ʻōpū, ke poʻo, ka ʻāʻī, ka umauma, a me ka ovary. A ʻo 5-FU ka lāʻau lapaʻau mua no ka maʻi maʻi colorectal ma ke keʻena. ʻO ka hana hana o 5-FU ka mea e ālai ai i ka hoʻololi ʻana o ka uracil nucleic acid i thymine nucleic acid i loko o nā pūnaewele tumo, a laila e hoʻopili i ka synthesis a me ka hoʻoponopono ʻana o DNA a me RNA e hoʻokō i kāna hopena cytotoxic (Afzal et al., 2009; Ducreux et. al., 2015; Longley et al., 2003). Eia nō naʻe, hoʻopuka ʻo 5-FU i ka maʻi maʻi chemotherapy-induced (CID), kekahi o nā hopena ʻino maʻamau e hoʻopilikia ai i nā maʻi he nui (Filho et al., 2016). ʻO ka nui o ka maʻi maʻi i nā maʻi i mālama ʻia me 5-FU a hiki i 50% -80%, ka mea i hoʻopilikia nui i ka holomua a me ka pono o ka chemotherapy (Iacovelli et al., 2014; Rosenoff et al., 2006). No laila, he mea koʻikoʻi ka loaʻa ʻana o ka lāʻau lapaʻau kūpono no 5-FU i hoʻokomo ʻia CID.

I kēia manawa, ua hoʻokomo ʻia nā hana lāʻau ʻole a me nā hana lāʻau i loko o ka lāʻau lapaʻau o CID. ʻO nā hana lāʻau ʻole he ʻai kūpono, a hoʻohui pū me ka paʻakai, ke kō a me nā meaʻai ʻē aʻe. Hoʻohana pinepine ʻia nā lāʻau lapaʻau e like me loperamide a me ka octreotide i ka anti-diarrhea therapy o CID (Benson et al., 2004). Eia kekahi, ua hoʻohana ʻia nā ethnomedicines e mālama iā CID me kā lākou ʻokoʻa kūʻokoʻa ma nā ʻāina like ʻole. ʻO ka lāʻau lapaʻau Kina kahiko (TCM) kekahi ethnomedicine maʻamau i hoʻomaʻamaʻa ʻia ma mua o 2000 mau makahiki ma nā ʻāina ʻĀkia Hikina me Kina, Iapana a me Korea (Qi et al., 2010). Manaʻo ʻo TCM e hoʻomaka ana nā lāʻau chemotherapeutic i ka hoʻohana ʻana i ka Qi, ka hemahema o ka spleen, ka ʻole o ka ʻōpū a me ka endophytic dampness, ka hopena i ka hana ʻino o ka ʻōpū. Ma ke kumumanaʻo TCM, pono e hilinaʻi nui ʻia ka hoʻolālā lapaʻau o CID i ka hoʻonui ʻana i ka Qi a me ka hoʻoikaika ʻana i ka spleen (Wang et al., 1994).

ʻO nā aʻa maloʻo oAtractylodes macrocephalaKoidz. (AM) aPanax ginsengCA Mey. (PG) nā lāʻau lapaʻau maʻamau i TCM me nā hopena like o ka hoʻonui ʻana i ka Qi a me ka hoʻoikaika ʻana i ka spleen (Li et al., 2014). Hoʻohana mau ʻia ʻo AM a me PG ma ke ʻano he mau mea kanu (ʻo ke ʻano maʻalahi o ka hoʻohālikelike ʻana i nā mea kanu Kina) me nā hopena o ka hoʻonui ʻana i ka Qi a me ka hoʻoikaika ʻana i ka spleen e mālama i ka maʻi maʻi. No ka laʻana, ua kākau ʻia ʻo AM a me PG i loko o nā ʻano hana anti-diarrheal maʻamau e like me Shen Ling Bai Zhu San, Si Jun Zi Tang mai.Taiping Huimin Heji Ju Fang(Ka moʻokūʻauhau mele, Kina) a me Bu Zhong Yi Qi Tang maiPi Wei Lun(Yuan dynasty, Kina) (Fig. 1). Ua hōʻike ʻia kekahi mau noiʻi mua e loaʻa i nā ʻano ʻekolu ʻekolu ka hiki ke hoʻēmi i ka CID (Bai et al., 2017; Chen et al., 2019; Gou et al., 2016). Eia kekahi, ua hōʻike ʻia kā mākou noiʻi mua ʻana ʻo Shenzhu Capsule nona ka AM a me PG wale nō ka hopena i ka mālama ʻana i ka maʻi maʻi maʻi, colitis (xiexie syndrome), a me nā maʻi ʻeha ʻē aʻe (Feng et al., 2018). Eia naʻe, ʻaʻohe haʻawina i kūkākūkā i ka hopena a me ka hana o AM a me PG i ka mālama ʻana iā CID, inā i hui pū ʻia a i ʻole.

I kēia manawa ua manaʻo ʻia ka microbiota gut he kumu kūpono i ka hoʻomaopopo ʻana i ka hana therapeutic o TCM (Feng et al., 2019). Hōʻike nā haʻawina hou he mea koʻikoʻi ka microbiota gut i ka mālama ʻana i ka homeostasis intestinal. Hāʻawi ka microbiota gut olakino i ka pale mucosal intestinal, metabolism, immune homeostasis a me ka pane ʻana, a me ka hoʻopau ʻana i ka pathogen (Thursby and Juge, 2017; Pickard et al., 2017). Hoʻopilikia ka microbiota gut maʻi i nā hana physiological a me ka pale ʻana o ke kino o ke kanaka ma ke ʻano pololei a ʻaʻole pololei paha, e hoʻoulu ai i nā hopena ʻaoʻao e like me ka maʻi maʻi (Patel et al., 2016; Zhao a me Shen, 2010). Ua hōʻike ʻia nā noiʻi ua hoʻololi ka 5-FU i ke ʻano o ka microbiota gut i nā ʻiole diarrheic (Li et al., 2017). No laila, hiki ke hoʻopili ʻia nā hopena o AM a me PM ma 5-FU i hoʻokomo ʻia i ka maʻi maʻi e ka ʻōpū microbiota. Eia naʻe, inā ʻo AM a me PG wale nō a me ka hui pū ʻana hiki ke pale i ka maʻi maʻi 5-FU ma o ka hoʻololi ʻana i ka microbiota gut ʻaʻole maopopo.

I mea e noiʻi ai i nā hopena anti-diarrhea a me ke ʻano kumu o AM a me PG, ua hoʻohana mākou i ka 5-FU e hoʻohālike i kahi hoʻohālike diarrheal i nā ʻiole. Maʻaneʻi, ua nānā mākou i nā hopena kūpono o ka hoʻokele hoʻokahi a hui pū ʻia (AP) oAtractylodes macrocephalaʻaila nui (AMO) aPanax ginsengka nui o saponins (PGS), nā mea ikaika i unuhi ʻia mai AM a me PG, ma ka maʻi maʻi maʻi, pathology intestinal a me ka microbial structure ma hope o 5-FU chemotherapy.


Huahana Huahana

Huahana Huahana

Ethnopharmacological pili

ʻO ka lāʻau lapaʻau Kina(TCM) paʻa ʻo ka hemahema o ka spleen-Qi ʻo ia ka pathogenesis nui o ka chemotherapy-induced diarrhea (CID). Laau lau oAtractylodesmacrocephalaKoidz. (AM) aPanax ginsengCA Mey. (PG) loaʻa nā hopena maikaʻi o ka hoʻonui ʻana i ka Qi a me ka hoʻoikaika ʻana i ka spleen.

Pahu o ka haʻawina

No ka noiʻi ʻana i nā hopena therapeutic a me nā mīkini oAtractylodes macrocephalaʻaila nui (AMO) aPanax ginsenghuinanā saponins(PGS) wale nō a me ka hui pū ʻana (AP) ma 5-fluorouracil (5-FU) chemotherapy i hoʻokomo ʻia i ka maʻi maʻi i nā ʻiole.

Nā mea a me nā ʻano hana

Hāʻawi ʻia nā ʻiole me AMO, PGS a me AP no 11 mau lā, a intraperitoneally injected me 5-FU no nā lā 6 mai ka lā 3rd o ka hoʻokolohua. I ka wā o ka hoʻokolohua, ua hoʻopaʻa ʻia ke kaumaha o ke kino a me nā helu ʻiole i kēlā me kēia lā. Ua helu ʻia nā ʻōlelo kuhikuhi Thymus a me ka spleen ma hope o ka mōhai ʻana o nā ʻiole. Ua nānā ʻia nā loli pathological i ka ileum a me nā ʻiʻo colonic e ka hematoxylin-eosin (HE) staining. A ua ana ʻia nā pae maʻiʻo o nā cytokine inflammatory intestinal e nā enzyme-linked immmunosorbent assays (ELISA).16S rDNAUa hoʻohana ʻia ʻo Amplicon Sequencing e nānā a wehewehe i kaʻōpū microbiotao na laana fecal.

Nā hualoaʻa

Kāohi loa ʻo AP i ka lilo ʻana o ke kaumaha o ke kino, ka maʻi maʻi, ka hoʻemi ʻana o nā thymus a me nā index spleen, a me nā loli pathological o nā ileums a me nā kolone i hoʻoulu ʻia e 5-FU. ʻAʻole ʻo AMO a i ʻole PGS wale nō i hoʻomaikaʻi nui i nā mea ʻino i ʻōlelo ʻia ma luna. Ma waho aʻe, hiki i ka AP ke kāohi nui i ka piʻi ʻana o 5-FU-mediated o nā cytokines intestinal inflammatory (TNF-α, IFN-γ, IL-6, IL-1βa me IL-17), ʻoiai ʻo AMO a i ʻole PGS i kāohi wale i kekahi o lākou ma hope o 5-FU chemotherapy. Ua hōʻike ʻia ka hōʻike ʻana i ka microbiota Gut ua hoʻohuli ʻo 5-FU i nā loli hoʻololi holoʻokoʻa oʻōpū microbiotaua hoʻohuli ʻia ma hope o ka mālama ʻana i ka AP. Hoʻohui hou, ua hoʻololi nui ʻo AP i ka nui o nā phyla like ʻole e like me nā waiwai maʻamau, a hoʻihoʻi i nā lakio oʻO Firmicutes/Bacteroidtes(F/B). I ka pae genus, ua emi loa ka lapaau AP i na pathogens likeBacteroides,Ruminococcus,AnaerotruncusaDesulfovibrio. Ua kūʻē ʻo AP i nā hopena kūlohelohe o AMO a me PGS wale nō ma kekahi mau genera likeʻO Blautia,ParabacteroidesaLactobacillus. ʻAʻole ʻo AMO a i ʻole PGS wale nō i kāohi i ka hoʻololi ʻana o ke ʻano microbial gut i hana ʻia e 5-FU.




  • Mua:
  • Aʻe:

  • E kākau i kāu leka ma aneʻi a hoʻouna mai iā mākou